213 related articles for article (PubMed ID: 23531523)
1. Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention.
Basili M; Ferrini S; Montomoli E
Eur J Public Health; 2013 Aug; 23(4):669-73. PubMed ID: 23531523
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of the vaccination program against seasonal and pandemic A/H1N1 influenza among customs officers in Greece.
Mamma M; Spandidos DA
Health Policy; 2013 Jan; 109(1):71-7. PubMed ID: 23195436
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against influenza: role and limitations in pandemic intervention plans.
Rebmann T; Zelicoff A
Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the most effective distribution strategies to assure administration of pandemic H1N1 influenza vaccine to New York State children and adolescents: evaluation using the New York State Immunization Information System.
Bednarczyk RA; DuVall S; Meldrum MD; Flynn MK; Santilli LA; Easton DE; Sharma P; Blog DS; Zansky SM; McNutt LA; Birkhead GS
J Public Health Manag Pract; 2013; 19(6):589-97. PubMed ID: 23299656
[TBL] [Abstract][Full Text] [Related]
5. Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.
Seib K; Chamberlain A; Wells K; Curran E; Whitney EA; Orenstein WA; Hinman AR; Omer SB
Hum Vaccin Immunother; 2014; 10(10):2915-21. PubMed ID: 25483633
[TBL] [Abstract][Full Text] [Related]
6. Assessing households' willingness to pay for an immediate pandemic influenza vaccination programme.
Asgary A
Scand J Public Health; 2012 Jul; 40(5):412-7. PubMed ID: 22798286
[TBL] [Abstract][Full Text] [Related]
7. Pandemic influenza A (H1N1) 2009 vaccine: an update.
Goel MK; Goel M; Khanna P; Mittal K
Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
[TBL] [Abstract][Full Text] [Related]
8. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
[TBL] [Abstract][Full Text] [Related]
9. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
10. Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.
Domingues CM; de Oliveira WK;
Vaccine; 2012 Jul; 30(32):4744-51. PubMed ID: 22609010
[TBL] [Abstract][Full Text] [Related]
11. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
Abelin A; Colegate T; Gardner S; Hehme N; Palache A
Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
[TBL] [Abstract][Full Text] [Related]
12. System factors to explain H1N1 state vaccination rates for adults in US emergency response to pandemic.
Davila-Payan C; Swann J; Wortley PM
Vaccine; 2014 May; 32(25):3088-93. PubMed ID: 23727421
[TBL] [Abstract][Full Text] [Related]
13. Pandemic H1N1 influenza: predicting the course of a pandemic and assessing the efficacy of the planned vaccination programme in the United States.
Towers S; Feng Z
Euro Surveill; 2009 Oct; 14(41):19358. PubMed ID: 19883540
[TBL] [Abstract][Full Text] [Related]
14. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
Sander B; Bauch CT; Fisman D; Fowler RA; Kwong JC; Maetzel A; McGeer A; Raboud J; Scales DC; Gojovic MZ; Krahn M
Vaccine; 2010 Aug; 28(38):6210-20. PubMed ID: 20643091
[TBL] [Abstract][Full Text] [Related]
15. Modelling the risk-benefit impact of H1N1 influenza vaccines.
Phillips LD; Fasolo B; Zafiropoulous N; Eichler HG; Ehmann F; Jekerle V; Kramarz P; Nicoll A; Lönngren T
Eur J Public Health; 2013 Aug; 23(4):674-8. PubMed ID: 23402804
[TBL] [Abstract][Full Text] [Related]
16. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing uptake of influenza vaccine amongst healthcare workers in a regional center after the A(H1N1) 2009 pandemic: lessons for improving vaccination rates.
Tagajdid MR; El Annaz H; Belefquih B; Doblali T; Casalegno JS; Mekki Y; Mrani S
Int J Risk Saf Med; 2011; 23(4):249-54. PubMed ID: 22156090
[TBL] [Abstract][Full Text] [Related]
18. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
[TBL] [Abstract][Full Text] [Related]
19. Modeling optimal age-specific vaccination strategies against pandemic influenza.
Lee S; Golinski M; Chowell G
Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
